Twenty four hour insulin infusion impairs the ability of plasma from healthy subjects and Type 2 diabetic patients to promote cellular cholesterol efflux

Atherosclerosis

Volumn 157, Issue 1, 2001, Pages 49-56

  Dullaart, Robin P F ^a   Van Tol, Arie ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Cholesterol efflux; Fu5AH cells; High density lipoproteins; Phospholipid transfer protein; Pre high density lipoproteins; Type 2 diabetes mellitus

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INSULIN; METFORMIN; PHOSPHOLIPID; PHOSPHOLIPID TRANSFER PROTEIN; SULFONYLUREA;

ADULT; ARTICLE; CELL TRANSPORT; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EFFUSION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYPERINSULINEMIA; INCUBATION TIME; INSULIN INFUSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PARAMETER; PATIENT; PHOSPHOLIPID TRANSFER; PLASMA; PRIORITY JOURNAL;

ADULT; BIOLOGICAL TRANSPORT; BLOOD PROTEINS; CELLS, CULTURED; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; MIDDLE AGED;

EID: 0034966488     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00691-2     Document Type: Article

References (63)

1. High-density lipoprotein - The clinical implications of recent studies
2. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis
3. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit
4. Molecular physiology of reverse cholesterol transport
5. Cholesteryl ester transfer protein, reverse cholesterol transport, and atherosclerosis
6. Molecular mechanisms of reverse cholesterol transport
7. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux
8. Scavenger class B type I as a mediator of cellular to lipoproteins and phospholipid acceptors
9. Cell cholesterol efflux: Integration of old and new observations provides new insights
10. The ABCs of cholesterol efflux
11. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
12. Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein
13. 1-HDL
14. High density lipoprotein metabolism
15. Cholesteryl ester transfer between lipoproteins
16. Plasma cholesteryl ester transfer protein
17. Human plasma phospholipid transfer protein causes high density lipoprotein conversion
18. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein
19. The mechanism of plasma lipid transfer protein-induced enlargement of high-density lipoprotein particles: Evidence for particle fusion
20. Human phospholipid transfer protein increases the anti-atherogenic potential of high density lipoproteins in transgenic mice
21. Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: Importance of LpA-I:A-II particles and phospholipid transfer protein
22. Insulin and risk of cardiovascular disease. A meta-analysis
23. Why is insulin not a risk factor for coronary heart disease?
24. Insulin resistance, compensatory hyperinsulinaemia and coronary heart disease
25. Insulin excess counteracts the effects of HDL on intracellular sterol accumulation in cultured human skin fibroblasts
26. Influence of insulin on cholesterol removal from macrophages and cholesterol ester uptake by HepG2 cells
27. Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration
28. Suppression of plasma cholesteryl ester transfer protein activity in acute hyperinsulinemia and effect of plasma nonesterified fatty acid
29. Response of adipose tissue lipoprotein lipase activity and serum lipoproteins to acute hyperinsulinaemia in man
30. The effect of acute hyperinsulinemia on plasma cholesteryl ester transfer protein activity in patients with non-insulin-dependent diabetes mellitus and healthy subjects
31. Lowering of plasma phospholipid transfer protein activity by acute hyperglycaemia-induced hyperinsulinaemia in healthy men
32. Plasma phospholipid transfer protein activity is related to insulin resistance: Impaired acute lowering by insulin in obese Type II diabetic patients
33. Human noninsulin-dependent diabetes: Identification of a defect in plasma cholesterol transport normalized in vivo by insulin and in vitro by selective immunoabsorption of apolipoproten E
34. Abnormal reverse cholesterol transport in controlled Type II diabetic patients
35. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification and transfer
36. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
37. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification diabetes mellitus. Provisional report of a WHO consultation
38. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men
39. Menstrual cycle effect on plasma lipids
40. Heated hand vein blood is satisfactory for measurements during free fatty acid kinetic studies
41. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein
42. Effect of adiposity on plasma lipid transfer protein activities: A possible link between insulin resistance and high density lipoprotein metabolism
43. Presence and formation of 'free apolipoprotein A-I-like' particles in human plasma
44. Metabolism of low-density lipoprotein free cholesterol by human plasma lecithin: Cholesterol acyltransferase
45. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma
46. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum
47. Role of HDL phospholipid in efflux of cell cholesterol to whole serum: Studies with human apoA-I transgenic rats
48. Modification of the cholesterol efflux properties of human serum by enrichment with phospholipid
49. Increased pre β-high density lipoprotein, apolipoprotein A1, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotrein AI transgenes
50. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins
51. Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein
52. Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities
53. Increased preβ-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes
54. 2
55. Apolipoprotein A-I-containing lipoproteins, with or without apolipoprotein A-II as progenitors of pre-β high-density-lipoprotein particles
56. Regulation of preβ high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol-acyltransferase activity
57. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-β particle formation by serum from human apolipoprotein A-I and apolipoprotein AI/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport
58. Prebeta-migrating high density lipoprotein: Quantitation in normal and hyperlipidemic plasma by solid phase radioimmunoassay following electrophoretic transfer
59. Pre β1-high-density lipoprotein increases in coronary heart disease
60. Prebeta-1 HDL in plasma of normolipidemic individuals: Influences of plasma lipoproteins, age and gender
61. Nonenzymatic glycosylation of HDL and impaired HDL-receptor-mediated cholesterol efflux
62. Effect of LCAT on HDL-mediated cholesterol efflux from loaded EA.hy 926 cells
63. Insulin increases plasma cholesteryl ester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes